Cargando…
BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma
Type II germ cell cancers (GCC) can be subdivided into seminomas and non-seminomas. Seminomas are similar to carcinoma in situ (CIS) cells, the common precursor of type II GCCs, with regard to epigenetics and expression, while embryonal carcinomas (EC) are totipotent and differentiate into teratomas...
Autores principales: | Nettersheim, Daniel, Jostes, Sina, Sharma, Rakesh, Schneider, Simon, Hofmann, Andrea, Ferreira, Humberto J., Hoffmann, Per, Kristiansen, Glen, Esteller, Manel B., Schorle, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520454/ https://www.ncbi.nlm.nih.gov/pubmed/26226633 http://dx.doi.org/10.1371/journal.pgen.1005415 |
Ejemplares similares
-
The cancer/testis-antigen PRAME supports the pluripotency network and represses
somatic and germ cell differentiation programs in seminomas
por: Nettersheim, Daniel, et al.
Publicado: (2016) -
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
por: Nettersheim, Daniel, et al.
Publicado: (2016) -
TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo
por: Nettersheim, Daniel, et al.
Publicado: (2019) -
A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment
por: Nettersheim, Daniel, et al.
Publicado: (2016) -
Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors
por: Nettersheim, Daniel, et al.
Publicado: (2018)